04Aug 2023
Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial

Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial

A study revealed a sharp drop in epilepsy cases after intensified onchocerciasis elimination efforts. A biannual ivermectin treatment and vector control reduced epilepsy incidence from 348.8 to 41.7 per 100,000 person-years between 2018 and 2022. Key risk factors identified include proximity to breeding sites, age (6-40), gender, and treatment adherence. Challenges persist, calling for sustained community-directed treatment and vector control to maintain gains against these conditions.

  • #pediatrics

Like

Save

Share